Ebun Eno‐Amooquaye

570 total citations
8 papers, 476 citations indexed

About

Ebun Eno‐Amooquaye is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ebun Eno‐Amooquaye has authored 8 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Ebun Eno‐Amooquaye's work include Berberine and alkaloids research (2 papers), Cancer therapeutics and mechanisms (2 papers) and Alkaloids: synthesis and pharmacology (2 papers). Ebun Eno‐Amooquaye is often cited by papers focused on Berberine and alkaloids research (2 papers), Cancer therapeutics and mechanisms (2 papers) and Alkaloids: synthesis and pharmacology (2 papers). Ebun Eno‐Amooquaye collaborates with scholars based in United Kingdom, Thailand and United States. Ebun Eno‐Amooquaye's co-authors include Peter J. Houghton, Philip J. Burke, Amala Raman, Julia Sampson, Arunporn Itharat, Niwat Keawpradub, Peter Burke, Stephen J. Gregson, Marina Sagnou and Philip W. Howard and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Ethnopharmacology.

In The Last Decade

Ebun Eno‐Amooquaye

8 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ebun Eno‐Amooquaye United Kingdom 8 237 151 124 103 60 8 476
Orasa Pancharoen Thailand 14 203 0.9× 182 1.2× 143 1.2× 45 0.4× 44 0.7× 21 424
Jian-Qiao Gu United States 8 301 1.3× 76 0.5× 168 1.4× 83 0.8× 59 1.0× 8 542
Maryam Hajrezaie Malaysia 13 151 0.6× 97 0.6× 104 0.8× 93 0.9× 47 0.8× 16 512
Toshiro Noshita Japan 13 295 1.2× 120 0.8× 86 0.7× 142 1.4× 50 0.8× 42 511
Hiroshi Kuwajima Japan 14 331 1.4× 80 0.5× 240 1.9× 111 1.1× 47 0.8× 34 527
Rubén Torrenegra Colombia 12 196 0.8× 63 0.4× 160 1.3× 65 0.6× 78 1.3× 44 386
Nóra Gyémánt Hungary 18 410 1.7× 99 0.7× 85 0.7× 117 1.1× 49 0.8× 24 734
Neetu Singh India 11 208 0.9× 92 0.6× 120 1.0× 145 1.4× 56 0.9× 12 517
Kim‐Hong Gan Taiwan 14 297 1.3× 85 0.6× 121 1.0× 170 1.7× 114 1.9× 18 602
Yasunobu Asao Japan 10 327 1.4× 62 0.4× 134 1.1× 81 0.8× 63 1.1× 15 545

Countries citing papers authored by Ebun Eno‐Amooquaye

Since Specialization
Citations

This map shows the geographic impact of Ebun Eno‐Amooquaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebun Eno‐Amooquaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebun Eno‐Amooquaye more than expected).

Fields of papers citing papers by Ebun Eno‐Amooquaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebun Eno‐Amooquaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebun Eno‐Amooquaye. The network helps show where Ebun Eno‐Amooquaye may publish in the future.

Co-authorship network of co-authors of Ebun Eno‐Amooquaye

This figure shows the co-authorship network connecting the top 25 collaborators of Ebun Eno‐Amooquaye. A scholar is included among the top collaborators of Ebun Eno‐Amooquaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebun Eno‐Amooquaye. Ebun Eno‐Amooquaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Barrie, S. Elaine, Ebun Eno‐Amooquaye, Anthea Hardcastle, et al.. (2003). High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Analytical Biochemistry. 320(1). 66–74. 23 indexed citations
2.
Itharat, Arunporn, Peter J. Houghton, Ebun Eno‐Amooquaye, et al.. (2003). In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. Journal of Ethnopharmacology. 90(1). 33–38. 240 indexed citations
3.
Sagnou, Marina, Philip W. Howard, Stephen J. Gregson, et al.. (2000). Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT. Bioorganic & Medicinal Chemistry Letters. 10(18). 2083–2086. 23 indexed citations
4.
Keawpradub, Niwat, Ebun Eno‐Amooquaye, Philip J. Burke, & Peter J. Houghton. (1999). Cytotoxic Activity of Indole Alkaloids from Alstonia macrophylla. Planta Medica. 65(4). 311–315. 79 indexed citations
5.
Khan, Tariq H, et al.. (1999). Novel Inhibitors of Carboxypeptidase G2 (CPG2):  Potential Use in Antibody-Directed Enzyme Prodrug Therapy. Journal of Medicinal Chemistry. 42(6). 951–956. 14 indexed citations
6.
Houghton, Peter J., et al.. (1997). Activity of Extracts and Alkaloids of ThaiAlstoniaSpecies Against Human Lung Cancer Cell Lines. Planta Medica. 63(2). 97–101. 77 indexed citations
7.
Lee, Moses, et al.. (1997). Synthesis of an aminopropyl analog of the experimental anticancer drug tallimustine, and activation of its 4-nitrobenzylcarbamoyl prodrug by nitroreductase and NADH. Bioorganic & Medicinal Chemistry Letters. 7(8). 1065–1070. 11 indexed citations
8.
Burke, P. J., et al.. (1996). Antibody-directed enzyme prodrug therapy (ADEPT). International Journal of Oncology. 9(3). 567–570. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026